To help guide its policy on direct-to-consumer (DTC) prescription drug advertising, the US Food and Drug Administration (FDA) plans to conduct two telephone surveys of patients and doctors about how the ads affected them.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments